CRBP — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

8.49

Margin Of Safety %

Put/Call OI Ratio

0.2

EPS Next Q Diff

0.03

EPS Last/This Y

1.04

EPS This/Next Y

-0.08

Price

9.77

Target Price

42.22

Analyst Recom

Performance Q

24.01

Upside

-900.6%

Beta

2.89

Ticker: CRBP

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	CRBP	9.51	0.03	0.00	8676
2026-03-10	CRBP	10.1	0.03	0.00	8976
2026-03-11	CRBP	10.38	0.03	0.00	9048
2026-03-12	CRBP	9.56	0.02	0.00	9759
2026-03-13	CRBP	9.59	0.02	0.00	9759
2026-03-17	CRBP	9.6	0.03	0.15	9781
2026-03-18	CRBP	9.05	0.03	0.01	9835
2026-03-19	CRBP	8.95	0.03	0.05	9969
2026-03-20	CRBP	8.61	0.03	0.03	9959
2026-03-23	CRBP	8.38	0.02	0.00	8403
2026-03-24	CRBP	8.21	0.01	0.00	10295
2026-03-25	CRBP	8.28	0.01	0.01	11110
2026-03-26	CRBP	9.26	0.01	0.31	12081
2026-03-27	CRBP	8.74	0.19	0.22	16050
2026-03-30	CRBP	8.59	0.19	0.00	16101
2026-03-31	CRBP	9.35	0.21	0.46	14663
2026-04-01	CRBP	10.01	0.21	0.13	14697
2026-04-02	CRBP	10.2	0.21	0.00	14852
2026-04-06	CRBP	10.08	0.20	0.01	15187
2026-04-07	CRBP	9.71	0.20	0.00	15447
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	CRBP	9.52	-102.0	-105.4	-6.71
2026-03-10	CRBP	10.08	-102.0	-50.1	-6.71
2026-03-11	CRBP	10.42	-102.0	-43.6	-6.71
2026-03-12	CRBP	9.60	-102.0	-14.9	-6.71
2026-03-13	CRBP	9.40	14.0	-27.3	-4.86
2026-03-17	CRBP	9.62	14.0	-34.5	-4.86
2026-03-18	CRBP	9.05	14.0	-17.9	-4.86
2026-03-19	CRBP	8.91	14.0	-28.2	-4.86
2026-03-20	CRBP	8.61	14.0	-21.2	-4.86
2026-03-23	CRBP	8.40	14.0	-26.0	-4.86
2026-03-24	CRBP	8.19	14.0	119.1	-4.86
2026-03-25	CRBP	8.28	14.0	114.9	-4.86
2026-03-26	CRBP	9.26	14.0	71.5	-4.86
2026-03-27	CRBP	8.77	14.0	297.8	-4.86
2026-03-30	CRBP	8.60	14.0	100.6	-4.86
2026-03-31	CRBP	9.39	14.0	66.2	-4.86
2026-04-01	CRBP	10.01	14.0	-300.8	-4.86
2026-04-02	CRBP	10.26	14.0	-58.2	-4.86
2026-04-06	CRBP	10.07	14.0	-5.4	-4.86
2026-04-07	CRBP	9.77	14.0	12.5	-4.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	CRBP	-4.71	31.85	8.47
2026-03-10	CRBP	-4.71	31.85	8.47
2026-03-11	CRBP	-4.71	31.85	8.51
2026-03-12	CRBP	-4.66	31.85	8.42
2026-03-13	CRBP	-4.66	31.85	8.42
2026-03-17	CRBP	-4.66	31.63	8.42
2026-03-18	CRBP	-4.66	31.63	8.42
2026-03-19	CRBP	-4.66	31.63	8.42
2026-03-20	CRBP	-4.66	31.63	8.42
2026-03-23	CRBP	-4.66	31.63	8.42
2026-03-24	CRBP	-4.66	31.63	8.42
2026-03-25	CRBP	-4.66	31.63	8.49
2026-03-26	CRBP	-4.66	31.63	8.49
2026-03-27	CRBP	-4.66	31.63	8.49
2026-03-30	CRBP	-4.66	31.63	8.49
2026-03-31	CRBP	-4.66	31.63	8.49
2026-04-01	CRBP	-4.66	31.63	8.49
2026-04-02	CRBP	-4.66	31.63	8.49
2026-04-06	CRBP	-4.66	31.67	8.49
2026-04-07	CRBP	-4.66	31.67	8.49
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-1.25

Avg. EPS Est. Current Quarter

-1.2

Avg. EPS Est. Next Quarter

-1.22

Insider Transactions

-4.66

Institutional Transactions

31.67

Beta

2.89

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

85.8

Max Drawdown 5-Year %

-96.8

Target Price

42.22

P/E

Forward P/E

PEG

P/S

P/B

1.16

P/Free Cash Flow

EPS

-5.98

Average EPS Est. Cur. Y

-4.86

EPS Next Y. (Est.)

-4.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

1.32

Return on Equity vs Sector %

-80.7

Return on Equity vs Industry %

-64.2

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.35

EBIT Estimation

12.5

◆ CRBP Healthcare

$9.71

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

2/25

Volume

3/15

Valuation

12/20

TP/AR

3/10

Options

8/10

RSI

56.9

Range 1M

75.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

1/25

Growth

12/30

Estimates

2/20

Inst/Vol

11/15

Options

6/10

EPS Yr

22.2%

EPS NY

-6.8%

52W%

31.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +334.8% upside

Quality

2/30

Valuation

16/30

Growth

10/25

Stability

8/10

LT Trend

1/5

Upside

+334.8%

Quality

Corbus Pharmaceuticals Holdings

Sector: Healthcare

Industry: Biotechnology

Employees: 36

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

CRBP

Latest News

—

Caricamento notizie per CRBP…

stock quote shares CRBP – Corbus Pharmaceuticals Holdings Inc. Stock Price stock today

news today CRBP – Corbus Pharmaceuticals Holdings Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRBP – Corbus Pharmaceuticals Holdings Inc. yahoo finance google finance

stock history CRBP – Corbus Pharmaceuticals Holdings Inc. invest stock market

stock prices CRBP premarket after hours

ticker CRBP fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CRBP

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y